Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naïve Patients in Chile

• Constanza L. Vargas ,

  Contributed equally to this work with: Constanza L. Vargas, Manuel A. Espinoza

  Affiliation Centre of Clinical Research, Health Technology Assessment Unit, Pontificia Universidad Catolica de Chile, Santiago, Chile

  ⨯
• Manuel A. Espinoza ,

  Contributed equally to this work with: Constanza L. Vargas, Manuel A. Espinoza

  * E-mail: maespinoza@med.puc.cl

  Affiliations Centre of Clinical Research, Health Technology Assessment Unit, Pontificia Universidad Catolica de Chile, Santiago, Chile, Department of Public Health, Pontificia Universidad Catolica de Chile, Santiago, Chile

  ⨯
• Andrés Giglio,

  Affiliation Hospital Sotero del Río, Puente Alto, Santiago, Chile

  ⨯
• Alejandro Soza

  Affiliations Centre of Clinical Research, Health Technology Assessment Unit, Pontificia Universidad Catolica de Chile, Santiago, Chile, Department of Gastroenterology, Pontificia Universidad Catolica de Chile, Santiago Chile

  ⨯